Jeffrey C. Henise, Ph.D.
Affiliations: | Chemistry and Chemical Biology | University of California, San Francisco, San Francisco, CA |
Area:
signaling proteinsGoogle:
"Jeffrey Henise"Mean distance: 8.47 | S | N | B | C | P |
Parents
Sign in to add mentorJack Taunton | grad student | 2011 | UCSF | |
(Development of cell-active irreversible inhibitors of the human centrosomal kinase Nek2.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Henise J, Fontaine SD, Hearn BR, et al. (2019) In Vitro-In Vivo Correlation for the Degradation of Tetra-PEG Hydrogel Microspheres with Tunable β-Eliminative Crosslink Cleavage Rates International Journal of Polymer Science. 2019: 1-7 |
Hearn BR, Fontaine SD, Pfaff SJ, et al. (2018) Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Cerchiari AE, Samy KE, Todhunter ME, et al. (2016) Probing the luminal microenvironment of reconstituted epithelial microtissues. Scientific Reports. 6: 33148 |
Schneider EL, Henise J, Reid R, et al. (2016) Subcutaneously administered self-cleaving hydrogel-octreotide conjugates provide very long-acting octreotide. Bioconjugate Chemistry |
Henise J, Hearn BR, Santi DV, et al. (2016) Surgical sealants with tunable swelling, burst pressures, and biodegradation rates. Journal of Biomedical Materials Research. Part B, Applied Biomaterials |
Schneider EL, Henise J, Reid R, et al. (2016) Hydrogel drug delivery system using self-cleaving covalent linkers for once-a-week administration of exenatide. Bioconjugate Chemistry |
Henise J, Hearn BR, Ashley GW, et al. (2015) Biodegradable tetra-PEG hydrogels as carriers for a releasable drug delivery system. Bioconjugate Chemistry. 26: 270-8 |
Ashley GW, Henise J, Reid R, et al. (2013) Hydrogel drug delivery system with predictable and tunable drug release and degradation rates. Proceedings of the National Academy of Sciences of the United States of America. 110: 2318-23 |
Henise JC, Taunton J. (2011) Irreversible Nek2 kinase inhibitors with cellular activity Journal of Medicinal Chemistry. 54: 4133-4146 |